Antihypertensive effects of nifedipine ingredient been demonstrated but dose recommendations, long Effective safety and effect on Nifangin outcome remain unestablished. The simultaneous administration of nifedipine element digoxin may lead to reduced clearance resulting in an increase in plasma concentrations of digoxin. Nifedipine is a substrate of the CYP3A4 isoenzyme and its use is contraindicated with potent inducers of CYP3A4, such as St. Delavirdine is a potent inhibitor of the CYP3A4 and increased plasma concentrations of drugs extensively metabolized by this enzyme, such as nifedipine, should be expected with concurrent use of delavirdine.
Possible side effects of Nifangin include:
Nifangin is used to treat diseases such as: Angina Pectoris Prophylaxis, Heart Failure, High Blood Pressure, Hypertensive Emergency, Hypertrophic Cardiomyopathy, Migraine Prevention, Premature Labor, Raynaud's Syndrome.
Antibiotics cause very little effect when taken in acute overdosage.